Factsheet Change to item 18361

This page contains a factsheet on the 1 December 2020 changes to item 18361.

Page last updated: 17 November 2020

From 1 December 2020, amendments to MBS item 18361 for the treatment of moderate to severe upper limb spasticity due to cerebral palsy will enable Medicare benefits to be paid for injection of the patients who meet the same criteria as the Pharmaceutical Benefits Schedule (PBS) listed medicines.

PDF version Factsheet-Item-18361 (PDF 315 KB)
Word version Factsheet-Item-18361 (DOCX 96 KB)

In this section